Exelixis, Inc. (EXEL) Covered Calls

Exelixis, Inc. is committed to developing innovative therapies for cancer and other serious diseases.

You can sell covered calls on Exelixis, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for EXEL (prices last updated Fri 4:16 PM ET):

Exelixis, Inc. (EXEL) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
38.67	-0.27	37.26	38.97	2.0M	19	11

Covered Calls For Exelixis, Inc. (EXEL)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Nov 21	39	1.20	37.77	3.2%	53.1%
Dec 19	39	2.00	36.97	5.4%	39.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Exelixis, Inc. is a biopharmaceutical company, which engages in the developing and commercializing small molecule therapies for the treatment of cancer. Its two advanced assets are COMETRIQ and cobimetinib. The company focuses on their proprietary resources and development and commercialization of cabozantinib. Exelixis was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in South San Francisco, CA.

Top 10 Open Interest For Nov 21 Expiration				Top 5 High Yield
1.	IBIT covered calls	6.	INTC covered calls	1.	GHRS covered calls
2.	KVUE covered calls	7.	TLT covered calls	2.	IREN covered calls
3.	NVDA covered calls	8.	ASST covered calls	3.	SRPT covered calls
4.	SLV covered calls	9.	EEM covered calls	4.	UPST covered calls
5.	GLD covered calls	10.	HYG covered calls	5.	HUT covered calls

Want more examples? EXE Covered Calls | EXI Covered Calls